ArticleCureus2024
Breast Lesions in Qassim Region, Saudi Arabia: A Retrospective Study.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionA breast lesion is an unusual development in the breast tissue that typically appears as a lump or swelling. It encompasses a wide range of disorders, from benign to malignant, posing significant health challenges globally.
methodsThe study was a retrospective study conducted at King Fahad Specialist Hospital (KFSH), Buraidah, Qassim region in Saudi Arabia between March 10, 2017, and April 2, 2024. Data was cleaned, coded, and analyzed using SPSS version 27.
resultsThe results revealed that most (639 (79.7%)) patients had symptomatic clinical presentations, with breast lump (470 (73.5%)) being the main presenting symptom. The majority (565 (70.4%)) of the patients presented malignant conditions, while 237 (29.6%) presented benign conditions. Of the patients who presented benign conditions, more than half (131 (55.3%)) were fibroadenoma benign lesions. Stage IIB cancer was the most common, constituting 192 (33.9%) of the patients. No complications were reported in the majority (480 (85.0%)).
conclusionThe study revealed a considerably high prevalence of malignant conditions among patients. Fibroadenoma was the most common breast lesion type, followed by intra-ductal papilloma and benign phyllodes. Age and BMI were found to be the risk factors that predicted the development of breast cancers. Knowledge and awareness of the prevalence, risk factors, and treatment of breast illnesses, as well as early screening and diagnosis, promote better patient outcomes and healthcare delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.